Decentralized Clinical Trials Market to Reach $18.8 Billion by 2030 as Digital Health Infrastructure Reshapes Drug Development [Yahoo! Finance]
ICON plc - Ordinary Shares (ICLR)
Last icon plc - ordinary shares earnings: 4/22 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.iconplc.com
Company Research
Source: Yahoo! Finance
Boston, March 19, 2026 (GLOBE NEWSWIRE) -- The global market for decentralized clinical trials (DCTs) was valued at $8.8 billion in 2024 and is projected to reach $18.8 billion by the end of 2030, according to a new report from BCC Research. The market is expected to grow at a compound annual growth rate (CAGR) of 13.7% from 2025 through 2030. Decentralized clinical trials — which use digital tools, remote monitoring and local healthcare providers to conduct research outside traditional clinical sites — are fundamentally changing how pharmaceutical and biotechnology companies develop new therapies. The model gained significant traction during the pandemic and has since evolved into a strategic priority for drug developers seeking to improve patient recruitment, retention and trial diversity. Key Market Findings Market size : $8.8 billion in 2024, projected to reach $18.8 billion by 2030 Growth rate : 13.7% CAGR from 2025 to 2030 Leading region : North America accounted for
Show less
Read more
Impact Snapshot
Event Time:
ICLR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICLR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICLR alerts
High impacting ICON plc - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ICLR
News
- Icon (ICLR) was downgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "hold (c-)" to "sell (d+)".MarketBeat
- Lowey Dannenberg, P.C. is Investigating ICON PLC (NASDAQ: ICLR) for Potential Violations of the Federal Securities Laws and Encourages Investors to Contact the FirmGlobeNewswire
- Icon (ICLR) had its price target lowered by Citigroup Inc. from $200.00 to $120.00. They now have a "neutral" rating on the stock.MarketBeat
- Icon Public Limited Company Investigated by the Portnoy Law FirmGlobeNewswire
- Icon Limited Public Company. Investigated by the Portnoy Law FirmGlobeNewswire
ICLR
Earnings
- 10/22/25 - Beat
ICLR
Sec Filings
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- 3/18/26 - Form 3
- ICLR's page on the SEC website